Recent

% | $
Quotes you view appear here for quick access.

Cyclacel Pharmaceuticals, Inc. Message Board

brianisthebest1111 3 posts  |  Last Activity: Jul 29, 2015 11:13 PM Member since: Apr 7, 2008
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • brianisthebest1111 brianisthebest1111 Jul 29, 2015 11:13 PM Flag

    I'm willing to bet you that NVGN is $20 + in 3 years ;). Good luck with your short.

  • While Dr. Kelly is very bright in his own regard, he lacked the necessary business accumen to move the Novogen platform forward in a practical and realistic manner. His resignation paves the way for industry professionals with more business savvy to come in and optimize the ongoing development process.

    The company is in a great position and has plenty of financial resources to move the three initial oncology candidates into phase 1 and potentially phase 2 trials (depending on cash burn). I expect various collaborations with big pharma as well as large government grants to be received over the next few years.

    Overall, a more shrewd management team is going to be in place to steer the ship more effectively and I expect the market will react positively to tonight's release. From a raw valuation standpoint, Novogen's platform in its entirely is worth only about $16.5 million after cash. This is extremely low given the enormous potential. I look forward to the months ahead.

  • Reply to

    Words of Iain Ross

    by onesurfed Jul 28, 2015 11:11 PM
    brianisthebest1111 brianisthebest1111 Jul 29, 2015 1:16 PM Flag

    I also heard from Iain, but Yahoo is not letting me cut and paste his emails.

CYCC
0.6301-0.0399(-5.96%)Aug 3 3:57 PMEDT